Papers: 10.1155/2018/6703963

https://doi.org/10.1155/2018/6703963

Cost-Effectiveness of Olaratumab in Combination with Doxorubicin for Patients with Soft Tissue Sarcoma in the United States

Cited by: 5
Author(s): Santiago Zuluaga-Sanchez, Lisa M. Hess, Sorrel Wolowacz, Yulia D’yachkova, Emma Hawe, Adrian D. Vickers, James A. Kaye, David Bertwistle
Published: over 8 years ago

Software Mentions 1